Failsafe automation of Phase II clinical trial interim monitoring for stopping rules.
Clin Trials
; 7(1): 78-84, 2010 Feb.
Article
em En
| MEDLINE
| ID: mdl-20156959
ABSTRACT
BACKGROUND:
In Phase II clinical trials in cancer, preventing the treatment of patients on a study when current data demonstrate that the treatment is insufficiently active or too toxic has obvious benefits, both in protecting patients and in reducing sponsor costs. Considerable efforts have gone into experimental designs for Phase II clinical trials with flexible sample size, usually implemented by early stopping rules. The intended benefits will not ensue, however, if the design is not followed. Despite the best intentions, failures can occur for many reasons.PURPOSE:
The main goal is to develop an automated system for interim monitoring, as a backup system supplementing the protocol team, to ensure that patients are protected. A secondary goal is to stimulate timely recording of patient assessments.METHODS:
We developed key concepts and performance needs, then designed, implemented, and deployed a software solution embedded in the clinical trials database system.RESULTS:
The system has been in place since October 2007. One clinical trial tripped the automated monitor, resulting in e-mails that initiated statistician/investigator review in timely fashion.LIMITATIONS:
Several essential contributing activities still require human intervention, institutional policy decisions, and institutional commitment of resources.CONCLUSIONS:
We believe that implementing the concepts presented here will provide greater assurance that interim monitoring plans are followed and that patients are protected from inadequate response or excessive toxicity. This approach may also facilitate wider acceptance and quicker implementation of new interim monitoring algorithms.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Automação
/
Ensaios Clínicos Fase II como Assunto
/
Suspensão de Tratamento
/
Tomada de Decisões
Tipo de estudo:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limite:
Humans
Idioma:
En
Revista:
Clin Trials
Assunto da revista:
MEDICINA
/
TERAPEUTICA
Ano de publicação:
2010
Tipo de documento:
Article
País de afiliação:
Estados Unidos